Selumetinib represents a crucial class of pharmaceutical research compounds, functioning as a potent MEK inhibitor that blocks the mitogen-activated protein kinase pathway to inhibit tumor cell growth.… Read more

![Chemical structure of 5-((2,4-Dichlorophenyl)(nitroso)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-24-Dichlorophenylnitrosoamino-4-fluoro-N-2-hydroxyethoxy-1-methyl-1H-benzodimidazole-6-carboxamide.png&w=3840&q=75)
![Chemical structure of 5-((4-Bromo-2-chlorophenyl)(2-chloro-4-(4-fluoro-6-((2-hydroxyethoxy)carbamoyl)-1-methyl-1H-benzo[d]imidazol-5-yl)phenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-4-Bromo-2-chlorophenyl2-chloro-4-4-fluoro-6-2-hydroxyethoxycarbamoyl-1-methyl-1H-benzodimidazol-5-ylphenylamino-4-fluoro-N-2-hydroxyethoxy-1-methyl-.png&w=3840&q=75)
![Chemical structure of 5-((4-Bromo-2-chlorophenyl)(4-(6-((2-(tert-butoxy)ethoxy)carbamoyl)-4-fluoro-1-methyl-1H-benzo[d]imidazol-5-yl)-2-chlorophenyl)amino)-N-(2-(tert-butoxy)ethoxy)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-4-Bromo-2-chlorophenyl4-6-2-tert-butoxyethoxycarbamoyl-4-fluoro-1-methyl-1H-benzodimidazol-5-yl-2-chlorophenylamino-N-2-tert-butoxyethoxy-4-fluoro-1.png&w=3840&q=75)
![Chemical structure of 5-((4-Bromo-2-chlorophenyl)(4-(6-carboxy-4-fluoro-1-methyl-1H-benzo[d]imidazol-5-yl)-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-4-Bromo-2-chlorophenyl4-6-carboxy-4-fluoro-1-methyl-1H-benzodimidazol-5-yl-2-chlorophenylamino-4-fluoro-1-methyl-1H-benzodimidazole-6-carboxylic-Aci.png&w=3840&q=75)
![Chemical structure of 5-((4-Bromo-2-chlorophenyl)(nitroso)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-4-Bromo-2-chlorophenylnitrosoamino-4-fluoro-1-methyl-1H-benzodimidazole-6-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of 5-((4-Bromo-2-chlorophenyl)(nitroso)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-4-Bromo-2-chlorophenylnitrosoamino-4-fluoro-N-2-hydroxyethoxy-1-methyl-1H-benzodimidazole-6-carboxamide.png&w=3840&q=75)
![Chemical structure of 5-((4-Bromo-2-chlorophenyl)(nitroso)amino)-N-(2-(tert-butoxy)ethoxy)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-4-Bromo-2-chlorophenylnitrosoamino-N-2-tert-butoxyethoxy-4-fluoro-1-methyl-1H-benzodimidazole-6-carboxamide.png&w=3840&q=75)
![Chemical structure of 5-((4-Bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-4-Bromo-2-chlorophenylamino-4-fluoro-1-methyl-1H-benzodimidazole-6-carboxamide.png&w=3840&q=75)
![Chemical structure of 5-((4-Bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F606144-04-1-5-4-Bromo-2-chlorophenylamino-4-fluoro-1-methyl-1H-benzodimidazole-6-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of 5-(Bis(4-bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-Bis4-bromo-2-chlorophenylamino-4-fluoro-1-methyl-1H-benzodimidazole-6-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of 5-(Bis(4-bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-Bis4-bromo-2-chlorophenylamino-4-fluoro-N-2-hydroxyethoxy-1-methyl-1H-benzodimidazole-6-carboxamide.png&w=3840&q=75)
![Chemical structure of 5-(Bis(4-bromo-2-chlorophenyl)amino)-N-(2-(tert-butoxy)ethoxy)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-Bis4-bromo-2-chlorophenylamino-N-2-tert-butoxyethoxy-4-fluoro-1-methyl-1H-benzodimidazole-6-carboxamide.png&w=3840&q=75)


![Chemical structure of Methyl 4-fluoro-1-methyl-5-(methylamino)-1H-benzo[d]imidazole-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FMethyl-4-fluoro-1-methyl-5-methylamino-1H-benzodimidazole-6-carboxylate.png&w=3840&q=75)
![Chemical structure of Methyl 5-((4-bromo-2-chlorophenyl)(nitroso)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FMethyl-5-4-bromo-2-chlorophenylnitrosoamino-4-fluoro-1-methyl-1H-benzodimidazole-6-carboxylate.png&w=3840&q=75)
![Chemical structure of Methyl 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F606144-02-9-Methyl-5-4-bromo-2-chlorophenylamino-4-fluoro-1-methyl-1H-benzodimidazole-6-carboxylate.png&w=3840&q=75)













Selumetinib represents a crucial class of pharmaceutical research compounds, functioning as a potent MEK inhibitor that blocks the mitogen-activated protein kinase pathway to inhibit tumor cell growth. It is primarily utilized in the clinical investigation and treatment of various cancers, including thymic carcinoma, non-small cell lung cancer, and neurofibromatosis type 1-related plexiform neurofibromas. To support essential analytical testing, method validation, and rigorous quality control in pharmaceutical laboratories, this category offers high-quality reference standards, including the active pharmaceutical ingredient, identified process-related impurities, and drug metabolites like O-glucuronide. Furthermore, researchers rely on stable isotope labelled compounds to serve as internal standards during complex bioanalytical assays. By utilizing these high-purity materials for impurity profiling and precise quantitation, laboratories ensure the safety, efficacy, and consistency of drug development processes throughout the therapeutic pipeline.